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Introduction
IL-22 is a cytokine produced by T cells and innate lym-
phocytes. Its receptor is exclusively expressed by non
hematopoietic cells mostly epithelial cells and hepatocytes.
IL-22 has pathogenic or protective effects depending on
the model. A role for IL-22 is suggested in IMID such as
psoriasis, rheumatoid arthritis and Crohn disease. IL-22BP
is a soluble inhibitory receptor specific for IL-22 whose
cellular source and physiological role are mainly unknown.
Aims
To identify the cellular source of IL-22BP in vivo and its
regulation of expression.
Methods
Rat dendritic cells (DCs) were prepared from spleen.
Human DCs were derived from monocytes (MDDC) in
the presence of GM-CSF+IL-4. IL-22BP mRNA expression
was assessed by q-PCR. Immunostaining experiments
were performed with polyclonal and/or monoclonal Ab to
IL-22BP. IL-22BP in serum was identified by WB.
Results
IL-22BP mRNA was expressed at high levels in rat second-
ary lymphoid organs and intestine. In spleen, IL-22BP
mRNA was restricted to a CD4+SIRPA+ subset of DCs.
This expression was constitutive. Similar results were
obtained in lymph nodes. IL-22BP expression in DCs was
confirmed at the protein level. An even stronger expres-
sion was found in a subset of lymph DCs migrating from
gut. In mouse, IL-22BP expression appeared restricted to
the CD103+ subsets of intestine DCs. In human, immu-
nostaining experiments identified stellate IL-22BP+ cells in
colon lamina propria and dermis. In vitro, IL-22BP expres-
sion was induced during MDDC differentiation and reti-
noic acid receptor alpha agonist dramatically enhanced
this expression. IL-22BP expression was rapidly down-
regulated following maturation both in rat and human
DC. Finally, WB analysis revealed high levels of serum IL-
22BP in healthy volunteers.
Conclusion
These results indicate that tissue and lymphoid DCs are
a main source of IL-22BP suggesting a role for these
DCs in regulating IL-22 at epithelial barriers.
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